Skip to NavigationSkip to content


IBM uncovers "precision phishing campaign" targeting global COVID-19 vaccine cold chain supply

US tech firm IBM has reported that it has identified attempts by unknown parties to hack and disrupt elements of the global supply chain established to distribute soon-to-be-approved COVID-19 vaccines around the world.

IBM’s Security X-Force said on 3 December that it had uncovered evidence of a “precision phishing campaign” that attempted to exploit weaknesses in the cold chain needed to deliver COVID-19 vaccines like the ones in development from Moderna and Pfizer/BioNTech.

Novartis and IBM form breast cancer research partnership

Novartis is to join forces with tech giant IBM and its Watson Health platform to tackle advanced breast cancer with an outcome-based initiative, it has emerged.

Thinking big data

Published on 23/01/17 at 03:53pm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough for those in need of medication now. Ben Hargreaves takes a look at how data analytics are beginning to transform the pharmaceutical industry, from clinical trials to drug discovery.

Novo strikes up personalised diabetes treatment deal with Glooko

Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with a range of issues affecting patients with type 1 and 2 diabetes including treatment adherence and blood glucose management.

These offerings will be integrated within Novo’s digital health platform developed with IBM Watson Health, a “virtual doctor” born from the company’s partnership with IBM signed in 2015.

IBM and FDA collaborate to protect patient data with blockchain technology

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health data in a secure manner through blockchain technology. Blockchain technology first came to attention through cryptocurrency, such as Bitcoin, as a secure means of transferring funds; this technology could now be utilised to protect patient data.

Pfizer teams up with IBM Watson Health in immuno-oncology

Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson artificial intelligence system to analyse massive amounts of data, from millions of laboratory and data reports, combined with medical literature to seek new drug targets.

Celgene partners with IBM for new pharmacovigilance platform

IBM is set to join forces with Celgene to develop a new drug safety evaluation platform, it has emerged.

Running on Watson Health Cloud, the new “Watson for Patient Safety” will analyse the safety of pharmaceutical products both in the development stage and post-launch by utilising data gathered from anonymised medical records and FDA individual case safety reports, meaning potential risks can be identified quicker and much more efficiently. The pharmacovigilance platform also even learns as it digests more and more data.

Teva team up with IBM to tackle two challenges facing the pharma industry

Teva Pharmaceuticals and IBM have announced a partnership that will use IBM Watson Health Cloud with the aim of finding new treatment options and to improve chronic disease management. The partnership will be a three-year research collaboration using the IBM’s computing power to investigate the potential repurposing of existing drugs.

IBM and Quest forge precision cancer treatment partnership

IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise its Watson technology platform to advance precision medicine in cancer treatment in the US.

Cloud on the horizon: Cloud computing and the clinical trial

Published on 01/09/16 at 10:20am

Originally published in the September edition of Pharmafocus, Matt Fellows investigates how cloud computing may just be the answer the industry is looking for to cope with the increasingly unfeasibility of clinical trials.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches